Finally, we proved that pretreatment with ATP combined with IFN-γ was safe and effective in a mouse model of acute pneumonia as evidenced by the significant reduction in alveolar inflammatory cell infiltration and reduced IL-1β and TNF-α levels (Fig 6). The gene discussed is TNF; the disease is pneumonia.